FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded...
LONDON, Feb. 25, 2025 /PRNewswire/ -- Contura Orthopedics is pleased to announce the launch of Contura Orthopedics (Canada) Ltd., marking a...
Strategic partnership with Microsoft provides growth opportunity for Canary Speech, which aims to set new industry standards for managing mental...
New industry roadmap outlines best practices for advancing digital health innovation for the underserved pediatric population BOSTON, Feb. 25, 2025 /PRNewswire/...
The major rollout brings new opportunities for engagement, fostering connection and combating isolation to seniors all across the Southern United...
FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for...
- New Store Centrally Located in High-Traffic Retail Corridor in Delaware County, PA - Expansion of In-State Patient and Caregiver...
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results...
Preeminent retinal disease expert panel to support Alkeus’ development programs and scienceCAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alkeus...
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking...
Several subjects who received the highest dose in Phase 1 will also be included in Phase 2OCALA, Fla., Feb. 25,...
-- Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab -- PASADENA,...
Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary...
CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use...
AlterDiag has signed a long-term strategic partnership agreement with the Institut Pasteur for the development of new single-domain antibodies-based rapid...
Industry Leaders Bring Expertise in Healthcare Supply Chain, Technology, and FinanceDALLAS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cato, a leading...
SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology...
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25...
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,...